PMID: 8448515Jan 1, 1993Paper

Policies to halve smoking deaths

Addiction
J Townsend

Abstract

Britain still has amongst the highest mortality rates in the world for all the major smoking diseases. A third of all adults smoke cigarettes regularly and smoking causes one third of UK deaths in middle age. This paper discusses factors related to changes in smoking levels and concludes that without the intervention of government policies, smoking prevalence and the amount smoked per smoker is likely to rise, particularly for young people. Measures to reduce smoking are surveyed and estimates made of the maximum likely effects from health education, advertising control, general practitioner smoking cessation advice and public and work place policies. A pricing policy is suggested which, with the other policies could reduce cigarette consumption by a half so that only one in five adults smoke by the year 2000. Predictions are made of the effect of this policy package on lives and life years saved. Within twenty five years there would be 50,000 fewer deaths from smoking and half a million life years saved annually. This would rise to two thirds of a million within forty years. Deaths from lung cancer would fall by 38%. The quality of these life years saved would tend to the average for their age.

References

Sep 3, 1977·Lancet·A B Atkinson, J L Townsend
Jul 28, 1979·British Medical Journal·M A RussellC D Baker
Sep 1, 1979·British Medical Journal·G Fowler
Jun 4, 1977·British Medical Journal·R Doll, R Peto
Nov 23, 1991·Lancet·N J Wald
Sep 1, 1991·British Journal of Obstetrics and Gynaecology·J E HaddowN J Wald
Sep 1, 1991·Biological Psychiatry·M Bruce, M Lader
Feb 1, 1991·The Journal of Pediatrics
Jan 1, 1991·Public Health·F Eskin
Nov 1, 1990·Archives of Pathology & Laboratory Medicine·H Travers
Oct 1, 1990·British Journal of Addiction·M J Jarvis, A D McNeill
Mar 1, 1990·British Journal of Addiction·P P Aitken, D R Eadie
Dec 10, 1987·Nucleic Acids Research·B E SlatkoG G Wilson
Apr 1, 1988·British Journal of Addiction·J ChetwyndE Wells
Aug 3, 1985·British Medical Journal·A Williams
Jul 30, 1988·BMJ : British Medical Journal·C Godfrey, A Maynard
Apr 1, 1986·British Journal of Plastic Surgery·C Chapman
Jan 1, 1986·European Journal of Clinical Pharmacology·H QuidingP A Hynning
Aug 31, 1985·British Medical Journal·R J Jarrett
Dec 12, 1985·The New England Journal of Medicine·L RosenbergS Shapiro
Mar 1, 1968·The Journal of School Health·J P Dippo
Sep 1, 1984·Journal of Epidemiology and Community Health·M MurrayG Clarke
Jul 10, 1982·Journal of Health Economics·E M Lewitt, D Coate
Mar 8, 1958·Journal of the American Medical Association·E C HAMMOND, D HORN
Apr 26, 1962·The New England Journal of Medicine·J LISTER
Jul 5, 2007·Journal of Lipid Research·Barbara P AtshavesFriedhelm Schroeder

❮ Previous
Next ❯

Citations

Nov 7, 2002·International Journal of Cardiology·Samer JabbourAloyzio Achutti
Aug 19, 1999·Social Science & Medicine·H Sato
Nov 1, 1994·Addiction·M Raw, A McNeill
Jan 29, 2000·BMJ : British Medical Journal·T Marshall
Aug 5, 2000·BMJ : British Medical Journal·P Jha, F J Chaloupka
Jan 29, 2002·Journal of Epidemiology and Community Health·M Joffe, J Mindell
Jan 10, 2013·Annual Review of Public Health·Thomas A Gaziano, Neha Pagidipati
May 16, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Shari P FeirmanAndrea C Villanti
Aug 21, 2009·Nature Reviews. Cancer·Prabhat Jha
Nov 21, 2015·Royal Society Open Science·Yulia V Ivashchenko, Phillip J Clapham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.